Search by Drug Name or NDC

    NDC 49502-0500-02 EPIPEN 0.3 mg/.3mL Details

    EPIPEN 0.3 mg/.3mL

    EPIPEN is a INTRAMUSCULAR INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Specialty L.P.. The primary component is EPINEPHRINE.

    Product Information

    NDC 49502-0500
    Product ID 49502-500_43cac57b-eee5-49ac-85c3-5c34069e610b
    Associated GPIs 3890004000D540
    GCN Sequence Number 016879
    GCN Sequence Number Description epinephrine AUTO INJCT 0.3MG/0.3 INJECTION
    HIC3 J5F
    HIC3 Description ANAPHYLAXIS THERAPY AGENTS
    GCN 19862
    HICL Sequence Number 002050
    HICL Sequence Number Description EPINEPHRINE
    Brand/Generic Brand
    Proprietary Name EPIPEN
    Proprietary Name Suffix n/a
    Non-Proprietary Name epinephrine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR
    Active Ingredient Strength 0.3
    Active Ingredient Units mg/.3mL
    Substance Name EPINEPHRINE
    Labeler Name Mylan Specialty L.P.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA019430
    Listing Certified Through 2024-12-31

    Package

    NDC 49502-0500-02 (49502050002)

    NDC Package Code 49502-500-02
    Billing NDC 49502050002
    Package 2 CONTAINER in 1 CARTON (49502-500-02) / 1 SYRINGE, GLASS in 1 CONTAINER (49502-500-01) / .3 mL in 1 SYRINGE, GLASS
    Marketing Start Date 1987-12-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 292.748
    Pricing Unit EA
    Effective Date 2023-06-21
    NDC Description EPIPEN 2-PAK 0.3 MG AUTO-INJCT
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis